From discovery to licensure, the Adjuvant System story. - Wikidata - awgldk - TriplyDB

From discovery to licensure, the Adjuvant System story.

From discovery to licensure, the Adjuvant System story.

http://www.wikidata.org/entity/Q37619140

about

Different Adjuvants Induce Common Innate Pathways That Are Associated with Enhanced Adaptive Responses against a Model Antigen in Humans.Adjuvant formulations for virus-like particle (VLP) based vaccines.Vaccine Containing the Three Allelic Variants of the Plasmodium vivax Circumsporozoite Antigen Induces Protection in Mice after Challenge with a Transgenic Rodent Malaria Parasite.AS03- and MF59-Adjuvanted Influenza Vaccines in Children.Understanding modern-day vaccines: what you need to know.Challenges in adult vaccination.Strategies for Generating Diverse Antibody Repertoires Using Transgenic Animals Expressing Human Antibodies.Adjuvant-dependent enhancement of HIV Env-specific antibody responses in infant rhesus macaques Effective Combination Adjuvants Engage Both TLR and Inflammasome Pathways To Promote Potent Adaptive Immune Responses Augmentation of vaccine-induced humoral and cellular immunity by a physical radiofrequency adjuvant Adjuvanted influenza vaccines

P2860

Q40064119-CA0393A3-021F-4F30-97E4-1EC79CFAA7AA Q40093469-C502EA80-12E9-426E-8748-9BE1490AFCA6 Q42699604-972DDD86-55CC-4DA5-8372-3EA5D281DEE4 Q47658890-6F432D8A-72C7-4C6E-B8EE-F7FD4E593F68 Q48238411-9CA89904-75BB-4792-B071-EB25D182437E Q51773551-B0E9A19E-7A49-4D92-9F95-EF6545CF1CEA Q52643675-8AB2F2A3-F109-4FA1-B10E-F9C390834E1A Q56345991-117D0E0B-1159-447E-A9A7-A2162096C43D Q56944933-CC7FB7FF-7C2A-4EAF-94E1-88A353E20EB5 Q57070723-A4766FA5-84EE-4D21-9E48-D879C0BDFB80 Q57094841-351A1731-86C8-4503-BBA8-7BDFE7CC6EBC

P2860

From discovery to licensure, the Adjuvant System story.

http://www.wikidata.org/entity/Q37619140

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 16 September 2016

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

From discovery to licensure, the Adjuvant System story.

@en

From discovery to licensure, the Adjuvant System story.

@nl

type

label

From discovery to licensure, the Adjuvant System story.

@en

From discovery to licensure, the Adjuvant System story.

@nl

prefLabel

From discovery to licensure, the Adjuvant System story.

@en

From discovery to licensure, the Adjuvant System story.

@nl

P1433

Q37619140-3CCC11F0-B3EB-43CD-9197-8C257A944D13

P1476

Q37619140-0C039FC4-296F-42DD-A416-B63C150ECC50

P2093

Q37619140-41D3CE58-BD9B-41BC-9E8B-D3947F9AABFF

Q37619140-E78A2C4F-B83F-4F75-A870-F2581B646E43

P275

Q37619140-02E728BA-F247-4C6E-9BA2-6B0F9C9700FC

P2860

Q37619140-022E7962-51C7-4658-99C6-AB04F6858312

Q37619140-069FA053-7FA3-4BCE-99E8-A44BA1FD31C8

Q37619140-06D8E4BF-DE4C-4AB2-AEC0-55971391855B

Q37619140-0762B124-E148-4536-BA97-49033CAEC798

Q37619140-0966B60F-7293-4169-8082-824F5700EC44

Q37619140-0A9FB28B-20C9-4DA2-A28D-8513DC15E16A

Q37619140-0B03B109-E544-4C0A-B4A5-48E88CFADFCC

Q37619140-0CC00EE3-5A15-4D58-9FBE-BAAD1A187AF2

Q37619140-0D243C04-727C-41FB-8FE0-9E4D9ECD725F

Q37619140-0E67893F-759A-4DE0-9F10-6386DFC45CD0

P304

Q37619140-7A8ECCFB-4AE5-452B-8A19-2B53170BFE83

P31

Q37619140-126AFE8D-3059-4671-8455-E6B03969E67B

Q37619140-993CE9ED-EB2D-48AD-A1D9-EDED93DC498B

P356

Q37619140-CE3C9E8D-4F1A-473C-8108-3B232487996C

P433

Q37619140-217DB0D5-95D0-496F-96E4-F3255991CFC6

P478

Q37619140-ADE0CF7A-108F-42F2-997E-B9B76B1EF92A

P577

Q37619140-34DEF868-4DE4-48AA-8885-62E72E872AEF

Q37619140-56920536-9F13-4043-8698-563B62FD9118

P698

Q37619140-1219F568-2985-48C8-AF9D-5D17E6F991AC

P921

Q37619140-3DEE0AA5-04FA-478F-99E9-E993A7C88D23

P932

Q37619140-5CF84E65-5BA8-435F-B2CA-BF239756434B

P356

21645515.2016.1225635

P1433

Human Vaccines & Immunotherapeutics

P1476

From discovery to licensure, the Adjuvant System story.

@en

P2093

Alberta Di Pasquale

http://www.w3.org/2001/XMLSchema#string

Nathalie Garçon

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution 3.0 Unported

P2860

Estimates of pandemic influenza vaccine effectiveness in Europe, 2009-2010: results of Influenza Monitoring Vaccine Effectiveness in Europe (I-MOVE) multicentre case-control study

Efficacy of RTS,S/AS01E vaccine against malaria in children 5 to 17 months of age

Tissue signatures influence the activation of intrahepatic CD8(+) T cells against malaria sporozoites

Sustained efficacy up to 4.5 years of a bivalent L1 virus-like particle vaccine against human papillomavirus types 16 and 18: follow-up from a randomised control trial

Efficacy of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomised study in young women

Safety of the RTS,S/AS02D candidate malaria vaccine in infants living in a highly endemic area of Mozambique: a double blind randomised controlled phase I/IIb trial

Comparison of the immunogenicity and safety of Cervarix and Gardasil human papillomavirus (HPV) cervical cancer vaccines in healthy women aged 18-45 years

Approaching the asymptote? Evolution and revolution in immunology

T cell responses to the RTS,S/AS01(E) and RTS,S/AS02(D) malaria candidate vaccines administered according to different schedules to Ghanaian children

Circumsporozoite-specific T cell responses in children vaccinated with RTS,S/AS01E and protection against P falciparum clinical malaria

P304

19-33

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/21645515.2016.1225635

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

13

http://www.w3.org/2001/XMLSchema#string

P577

2016-09-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

2017-01-02T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27636098

http://www.w3.org/2001/XMLSchema#string

P921

biomedical investigative technique

P932

5287309

http://www.w3.org/2001/XMLSchema#string